NASDAQ: LIXTLixte Biotechnology Holdings Inc Stock Ownership - Who owns Lixte Biotechnology Holdings?
Insider buying vs selling
Have Lixte Biotechnology Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Der Baan Bastiaan Jeroen Van | Director | 2022-12-30 | 10,000 | $0.49 | $4.90kBuy |
| Der Baan Bastiaan Jeroen Van | Director | 2022-12-30 | 10,000 | $4.90 | $49.00kBuy |
| Der Baan Bastiaan Jeroen Van | Director | 2022-12-30 | 10,000 | $4.90 | $49.00kBuy |
| Rene Bernards | Director | 2022-12-15 | 15,000 | $0.51 | $7.65kBuy |
| Rene Bernards | Director | 2022-12-12 | 10,000 | $0.61 | $6.10kBuy |
| Eric Forman | Vice President and COO | 2022-12-09 | 1,112 | $0.63 | $700.56Buy |
| Eric Forman | Vice President and COO | 2022-12-09 | 10,000 | $0.60 | $6.00kBuy |
| Eric Forman | Vice President and COO | 2022-12-09 | 5,000 | $0.63 | $3.14kBuy |
| Eric Forman | Vice President and COO | 2022-11-22 | 2,484 | $0.56 | $1.39kBuy |
| Regina Brown | Director | 2022-11-21 | 2,400 | $0.57 | $1.37kBuy |
LIXT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LIXT insiders and whales buy or sell their stock.
LIXT Shareholders
What type of owners hold Lixte Biotechnology Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| John S. Kovach | 9.25% | 1,540,183 | $1.09M | Insider |
| Glenn Krinsky | 8.85% | 1,474,998 | $1.05M | Insider |
| Gil Schwartzberg | 7.06% | 1,176,388 | $835.24k | Insider |
| Robert 1. Greenberg | 5.97% | 994,299 | $705.95k | Insider |
| Ethos Financial Group LLC | 1.49% | 248,084 | $176.14k | Institution |
| Rene Bernards | 0.90% | 150,000 | $106.50k | Insider |
| Philip F. Palmedo | 0.64% | 107,056 | $76.01k | Insider |
| Geode Capital Management LLC | 0.61% | 101,209 | $71.86k | Institution |
| Stephen J. Forman | 0.45% | 74,804 | $53.11k | Insider |
| Morgan Stanley | 0.43% | 71,054 | $50.45k | Institution |
LIXT vs Biotech Stocks
Lixte Biotechnology Holdings Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.